LEN can stop HIV. But first people need to understand it
A researcher discusses the public health challenge of introducing lenacapavir (LEN), a long-acting HIV prevention injection, in Zambia. The article highlights a significant knowledge gap regarding the drug's purpose, as many mistake it for a cure rather than a preventative measure.
Why it matters
Effective public health communication is essential to ensure that new medical breakthroughs are used correctly to curb the spread of HIV.
The last person I expected to catch me off guard that summer’s evening was my 52-year-old aunt. We were roasting fresh maize around a fire in Chisamba, a rural farming town about 100km from Lusaka.
The article focuses on health education and personal narrative without taking a political stance.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in